MedTrace Logo

The Effect of Aerobic Exercise on Lower Urinary System Symptoms in Women With Diabetes Mellitus

NCT06249399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-03-05

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the effect of aerobic exercise (AE) on bladder functions and urinary system symptoms in women diagnosed with Diabetes Mellitus (DM) and suffered from Lower Urinary Tract Symptoms (LUTS). In the study, 44 individuals (35-55 age) were divided into two groups: Aerobic Exercise (AE) (n=22) and Control Group (n=22) by simple random method.

The main questions it aims to answer are:

* Is aerobic exercise effective on bladder functions in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
* Is aerobic exercise effective on urinary tract symptoms in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
* Is aerobic exercise effective on quality of life in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?

Intervention/treatment

* Control group individuals will be given a behavioral treatment program.
* Submaximal aerobic exercise training will be given to the AE group in addition to the behavioral treatment program.

Conditions

  • Lower Urinary Tract Symptoms
  • Diabetes Mellitus, Type 2

Interventions

OTHER

Aerobic Exercise

Aerobic Exercise training will be provided three days a week, 45 minutes a day, for 12 weeks. Patients will be subjected to submaximal aerobic exercise with rhythmic movements without equipment via video conference accompanied by a physiotherapist.

BEHAVIORAL

Behavioral Treatment Program

Behavioral Treatment Program will be completed with an initial training period of 40 minutes, and subsequent control interviews of 20 minutes at four-week intervals.

Sponsors & Collaborators

  • University of Gaziantep

    collaborator OTHER

  • Hasan Kalyoncu University

    collaborator OTHER

  • Gaziantep Islam Science and Technology University

    lead OTHER

Principal Investigators

  • Bengisu TÜFEKÇİ · Hasan Kalyoncu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-03
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06249399 on ClinicalTrials.gov